Document is current

Any future updates will be listed below

Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review

Crossref DOI link: https://doi.org/10.1186/s40842-025-00270-4

Published Online: 2026-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark